(Q33983562)

English

Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin

scientific article published on June 17, 2010

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Changes in 12-Year First-Line Eradication Rate of Helicobacter pylori Based on Triple Therapy with Proton Pump Inhibitor, Amoxicillin and Clarithromycin (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Helicobacter pylori

0 references

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Helicobacter pylori infectious disease

1 reference

based on heuristic

inferred from title

author name string

Makoto Sasaki

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Naotaka Ogasawara

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Keiko Utsumi

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Naohiko Kawamura

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Tskeshi Kamiya

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Hiromi Kataoka

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Satoshi Tanida

7

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Tsutomu Mizoshita

8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Kunio Kasugai

9

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Takashi Joh

10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

language of work or name

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20664731

11 June 2024

publication date

17 June 2010

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

full work available at URL

https://www.jstage.jst.go.jp/article/jcbn/47/1/47_10-10/_pdf

Portable Document Format

online access status

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664731

11 June 2024

http://www.jstage.jst.go.jp/article/jcbn/47/1/47_53/_article

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664731

11 June 2024

http://www.jstage.jst.go.jp/article/jcbn/47/1/53/_pdf

Portable Document Format

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664731

11 June 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20664731/?tool=EBI

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664731

11 June 2024

https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/20664731/pdf/?tool=EBI

Portable Document Format

online access status

content deliverer

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664731

11 June 2024

https://europepmc.org/articles/PMC2901764

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664731

11 June 2024

https://europepmc.org/articles/PMC2901764?pdf=render

Portable Document Format

online access status

content deliverer

Europe PubMed Central

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A20664731

11 June 2024

Journal of Clinical Biochemistry and Nutrition

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

47

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

53-58

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sitafloxacin and garenoxacin may overcome the antibiotic resistance of Helicobacter pylori with gyrA mutation

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

28 July 2018

Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

28 July 2018

H pylori eradication: a randomized prospective study of triple therapy with or without ecabet sodium

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

28 July 2018

Changing antimicrobial susceptibility epidemiology of Helicobacter pylori strains in Japan between 2002 and 2005.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

28 July 2018

CYP2C19 pharmacogenomics associated with therapy of Helicobacter pylori infection and gastro-esophageal reflux diseases with a proton pump inhibitor

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

28 July 2018

Helicobacter pylori: present status and future prospects in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

28 July 2018

Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

28 July 2018

Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

28 July 2018

Relationship between eradication therapy and clarithromycin-resistant Helicobacter pylori in Japan

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

28 July 2018

Quinolone-Based Third-Line Therapy for Helicobacter pylori Eradication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Evaluation of three different proton pump inhibitors with amoxicillin and metronidazole in retreatment for Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Helicobacter pylori: antibiotic resistance and eradication rates in Suffolk, UK, 1991-2001.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Rabeprazole treatment attenuated Helicobacter pylori-associated gastric mucosal lesion formation in Mongolian gerbils

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Risk factors for failure of Helicobacter pylori therapy--results of an individual data analysis of 2751 patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Eradication rates of clarithromycin-resistant Helicobacter pylori using either rabeprazole or lansoprazole plus amoxicillin and clarithromycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Primary resistance to antibiotics and its clinical impact on the efficacy of Helicobacter pylori lansoprazole-based triple therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Effects of CYP2C19 genotypic differences in the metabolism of omeprazole and rabeprazole on intragastric pH.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Clarithromycin resistance, but not CYP2C-19 polymorphism, has a major impact on treatment success in 7-day treatment regimen for cure of H. pylori infection: a multiple logistic regression analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

A multicenter, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Effects of genotypic differences in CYP2C19 status on cure rates for Helicobacter pylori infection by dual therapy with rabeprazole plus amoxicillin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Predictors of failure of Helicobacter pylori eradication with the standard 'Maastricht triple therapy'.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2901764

29 October 2018

Genotyping of S-mephenytoin 4'-hydroxylation in an extended Japanese population

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori and gastric cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

CYP2C19 genotype status and intragastric pH during dosing with lansoprazole or rabeprazole

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy of metronidazole as second-line drug for the treatment of Helicobacter pylori Infection in the Japanese population: a multicenter study in the Tokyo Metropolitan Area

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Helicobacter pylori eradication: a randomized prospective study of triple therapy versus triple therapy plus lactoferrin and probiotics

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rabeprazole-based eradication therapy for Helicobacter pylori: a large-scale study in Japan

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Dual therapy with high doses of rabeprazole and amoxicillin versus triple therapy with rabeprazole, amoxicillin, and metronidazole as a rescue regimen for Helicobacter pylori infection after the standard triple therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Evidence that the degree and duration of acid suppression are related to Helicobacter pylori eradication by triple therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of genetic differences in omeprazole metabolism on cure rates for Helicobacter pylori infection and peptic ulcer

1 reference

https://pubmed.ncbi.nlm.nih.gov/20664731

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.3164/JCBN.10-10

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33983562&oldid=2176797412"